16^th Asia Pacific Oncologists Annual Meeting

Non-Hodgkin’s lymphoma is one of the most common cancers worldwide. It primarily affects adults above the age of 50 years but it is not uncommon in children. Non-Hodgkin’s lymphoma is the cancer pertaining to lymphocytes, one of the types of leucocytes. As the lymphocytes multiply abnormally, of thymus, spleen, bone marrow and the lymph nodes present in the body tend to get affected. It has been associated with various risk factors like autoimmune disorders, smoking, immunosuppressive treatments and frequent infections. The recommended treatment for Non-Hodgkin’s lymphoma is an integrated chemotherapy and immunotherapy treatment. This treatment has considerable side effects like severe hair fall, allergic reactions; decrease in blood count especially the neutrophils that protect the body from infections. Other alternatives include radiotherapy, bone marrow transplant and radio immunotherapy. Many studies have been conducted in relation to the treatment of Non-Hodgkin’s Lymphoma with immunotherapy but the possibility of emergence of alternate effects has also not been entirely ruled out. This case report aims to establish the efficacy of oral immunotherapy treatment in a patient of Non-Hodgkin’s lymphoma in terms of the following: Relieving the patient of his presenting complaints, removing the evidence of the disease completely from the body without any side effects, ruling out relapse of the disease and ensuring a normal life to the patient.